Teva Pharmaceuticals Highlights Critical Treatment Gaps for Tardive Dyskinesia in Long-Term Care Facilities
Study reveals over half of long-term care residents with tardive dyskinesia do not receive standard treatment, highlighting care gaps.
Symbol | Last Price | Change | % Change |
---|---|---|---|